Amivas is a global pharmaceutical company specializing in the development, commercialization, and distribution of life-saving medicines, particularly Artesunate for severe malaria. Committed to improving health outcomes, Amivas plays a crucial role in the fight against malaria, contributing to better public health worldwide.
Specialties
Artesunate for severe malaria
Life-saving pharmaceutical development
Global distribution network
Joint venture collaboration
FDA-approved therapeutics
Products & Services
Artesunate for Severe Malaria
Life-Saving Medicines
Therapeutics for Life-Threatening Diseases
Commercialization and Distribution Services
Healthcare Solutions
Contact Information
No contact information available
Competitors & Similar Companies(10)
GSK (GlaxoSmithKline)
Hillingdon, • United Kingdom
Sanofi
Île-De-France, • France
Takeda Pharmaceutical Company
Tokyo, • Japan
Novartis
Basel-City, • Switzerland
Pfizer
New York, • United States
Merck & Co.
New Jersey, • United States
AstraZeneca
Greater London, • United Kingdom
Bristol Myers Squibb
New York, • United States
Roche
Basel-City, • Switzerland
Johnson & Johnson
New Jersey, • United States
News & Media
Search Terms:
amivas
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Amivas belongs to the Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Amivas?
Amivas specializes in Artesunate for severe malaria, Life-saving pharmaceutical development, Global distribution network, Joint venture collaboration, FDA-approved therapeutics.
What products and services is Amivas likely to offer?
Amivas offers Artesunate for Severe Malaria, Life-Saving Medicines, Therapeutics for Life-Threatening Diseases, Commercialization and Distribution Services, Healthcare Solutions.
Who are the competitors of Amivas?
Competitors of Amivas are GSK (GlaxoSmithKline), Sanofi, Takeda Pharmaceutical Company, Novartis, Pfizer, Merck & Co., AstraZeneca, Bristol Myers Squibb, Roche, Johnson & Johnson.
What does Amivas do?
Amivas is a global pharmaceutical company specializing in the development, commercialization, and distribution of life-saving medicines, particularly Artesunate for severe malaria. Committed to improving health outcomes, Amivas plays a crucial role in the fight against malaria, contributing to better public health worldwide.